Abstract:Primary osteoporosis is closely linked to hormone deficiency, which disrupts the balance of bone remodeling. It affects postmenopausal women but also significantly impacts older men. Estrogen can promote the production of osteoprotegerin, a decoy receptor for RANKL, thereby preventing RANKL from activating osteoclasts. Furthermore, estrogen promotes osteoblast survival and function via activation of the Wnt signaling pathway. Likewise, androgens play a critical role in bone metabolism, primarily through their conversion to estrogen in men. Estrogen deficiency accelerates bone resorption through a rise in pro-inflammatory cytokines (IL-1, IL-6, TNF-α) and RANKL, which promote osteoclastogenesis. In the classic genomic pathway, estrogen binds to estrogen receptors in the cytoplasm, forming a complex that migrates to the nucleus and binds to estrogen response elements on DNA, regulating gene transcription. Androgens can be defined as high-affinity ligands for the androgen receptor; their combination can serve as a ligand-inducible transcription factor. Hormone replacement therapy has shown promise but comes with associated risks and side effects. In contrast, the non-genomic pathway involves rapid signaling cascades initiated at the cell membrane, influencing cellular functions without directly altering gene expression. Therefore, the ligand-independent actions and rapid signaling pathways of estrogen and androgen receptors can be harnessed to develop new drugs that provide bone protection without the side effects of traditional hormone therapies. To manage primary osteoporosis, other pharmacological treatments (bisphosphonates, teriparatide, RANKL inhibitors, sclerostin inhibitors, SERMs, and calcitonin salmon) can ameliorate osteoporosis and improve BMD via actions on different pathways. Non-pharmacological treatments include nutritional support and exercise, as well as the dietary intake of antioxidants and natural products. The current study reviews the processes of bone remodeling, hormone actions, hormone receptor status, and therapeutic targets of primary osteoporosis. However, many detailed cellular and molecular mechanisms underlying primary osteoporosis seem complicated and unexplored and warrant further investigation.

Effects of estrogen on cytokines related to bone remodeling in orthodontic treatment

Appliance-induced osteopenia of dentoalveolar bone in the rat: effect of reduced bone strains on serum bone markers and the multifunctional hormone leptin.

The Effect of Astragalus Extractive on Alveolar Bone Rebuilding Progress of Tooth Extracted Socket of Ovariectomied Rats.

Reciprocal Roles Between Caffeine and Estrogen on Bone Via Differently Regulating Camp/pka Pathway: the Possible Mechanism for Caffeine-Induced Osteoporosis in Women and Estrogen’s Antagonistic Effects

Effects of estrogen on the alveolar bone remodeling and the expression of IL-1 osteoporotic rats

Estrogen regulates expression of osteoprotegerin and RANKL in human periodontal ligament cells through estrogen receptor beta.

Effect of 17-β estradiol on the expression of receptor activator of nuclear factor κB ligand and osteoprotegerin of human periodontal ligament cells during their osteogenic differentiation

Effect of Raloxifene and Estrogen on IL-1β Expression in Periodontitis-Associated Alveolar Bone in Osteoporotic Rats

Effect of estrogen depression on alveolar bone microarchitecture and periodontal ligament cells during orthodontic movement

Estrogen deficiency leads to impaired osteogenic differentiation of periodontal ligament stem cells in rats.

Osteoporotic osseointegration: therapeutic hallmarks and engineering strategies

Probiotics ameliorate alveolar bone loss by regulating gut microbiota

Alveolar Bone Changes In Maxillary And Mandibular Anterior Teeth During Orthodontic Treatment: A Systematic Review And Meta-Analysis

Effects of estrogen on osteoblast vascular endothelial growth factor expression during bone fracture healing in osteoporotic rats

The role of cannabinoid receptor 2 in bone remodeling during orthodontic tooth movement

Effect of estrogen receptor beta on the osteoblastic differentiation function of human periodontal ligament cells.

The effect of cytokines on osteoblasts and osteoclasts in bone remodeling in osteoporosis: a review

Effect of Bifidobacterium on osteoclasts: TNF-α/NF-κB inflammatory signal pathway-mediated mechanism

Age-related alveolar bone maladaptation in adult orthodontics: finding new ways out

The Molecular and Cellular Perspective on Pathophysiological Mechanisms and Treatments